The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials
Abstract
Context Safe and effective strategies to curb rising obesity prevalence rates are urgently needed and medications may play a more prominent role in future therapeutic regimens. Objective To review systematically the long-term efficacy and safety of approved antiobesity medications. Data sources MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Current Science Meta-register of Controlled Trials, and reference lists of original studies and reviews were searched. Drug manufacturers and two obesity experts were contacted. No language restrictions were imposed. Study selection Double-blind, randomized controlled studies of approved antiobesity medications with follow-up periods of 1 y or greater were eligible for inclusion. Data extraction Two reviewers independently assessed all potentially relevant studies for inclusion and methodological quality using standardized abstraction forms. Results A total of 11orlistat (n=6021) and three sibutramine (n=929) studies met inclusion criteria. Attrition rates averaged 33% in orlistat studies and 48% in sibutramine studies. A random effects model was used for meta-analysis. Compared to placebo, orlistat-treated patients displayed a 2.7 kg (95% CI: 2.3-3.1 kg) or 2.9% (95% CI: 2.3-3.4%) greater reduction in weight and patients on sibutramine displayed a 4.3 kg (95% CI: 3.6-4.9 kg) or 4.6% (95% CI: 3.8-5.4%) greater weight reduction after 1 y of follow-up. The number of patients achieving 10% or greater weight loss was 12% (95% CI: 8-…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pancreatic lipase inhibitor, orlistat blocks dietary fat absorption, resulting in ~3–5% weight loss.”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [57]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00131-0 · Cited by 2,379
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Weight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
Body Weight and Mortality among Women
Manson, J. E., Willett, W. C., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Hankinson, S. E., Hennekens, C. H., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331101 · Cited by 1,988
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Beneficial health effects of modest weight loss.
Dj, G. (1992) · PubMed · Cited by 1,263
Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M., Golay, A., Koppeschaar, H. P., & Krempf, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11509-4 · Cited by 1,237
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947
(1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1855 · Cited by 936
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Intentional weight loss and mortality among overweight individuals with diabetes.
Williamson, D. F., Thompson, T. J., Thun, M., Flanders, D., Pamuk, E., & Byers, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1499 · Cited by 558
Williamson, D. F., Pamuk, E., Thun, M., Flanders, D., Byers, T., & Heath, C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117386 · Cited by 527
Effect of Degree of Weight Loss on Health Benefits
Blackburn, G. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00466.x · Cited by 503
Rössner, S., Sjöström, L., Noack, R., Meinders, A. E., Noseda, G., & Study, O. B. O. T. E. O. O. (2000) · Obesity Research · doi:10.1038/oby.2000.8 · Cited by 476
Treatment of Obesity by Moderate and Severe Caloric Restriction: Results of Clinical Research Trials
Wadden, T. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00012 · Cited by 470
Investigating and Dealing with Publication and Other Biases
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch11 · Cited by 449
Long-term pharmacotherapy for obesity and overweight
Padwal, R. S., Rucker, D., Li, S. K., Curioni, C., & Lau, D. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004094.pub2 · Cited by 384
Self-citationOrlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367
The cost of obesity in Canada.
Birmingham, C. L., Muller, J. L., Palepu, A., Spinelli, J. J., & Anis, A. H. (1999) · Europe PMC (PubMed Central) · Cited by 353
Finer, N., James, W., Kopelman, P., Lean, M., & Williams, G. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801128 · Cited by 325
Kelley, D. E., Bray, G. A., Pi-Sunyer, F. X., Klein, S., Hill, J., Miles, J., & Hollander, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1033 · Cited by 314
Haddock, C., Poston, W., Dill, P., Foreyt, J., & Ericsson, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801889 · Cited by 303
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
Miles, J. M., Leiter, L., Hollander, P., Wadden, T., Anderson, J. W., Doyle, M., Foreyt, J., Aronne, L., & Klein, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1123 · Cited by 286
Khan, M. A., Herzog, C. A., St. Peter, J. V., Hartley, G. G., Madlon-Kay, R., Dick, C. D., Asinger, R. W., & Vessey, J. T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391101 · Cited by 265
A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve Regurgitation
Jick, H., Vasilakis, C., Weinrauch, L. A., Meier, C. R., Jick, S. S., & Derby, L. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391102 · Cited by 263
Systematic Reviews in Health Care
Loo, L. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00035 · Cited by 254
McMahon, F. G., Fujioka, K., Singh, B. N., Mendel, C. M., Rowe, E., Rolston, K., Johnson, F., & Mooradian, A. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2185 · Cited by 247
Assessing the Quality of Randomised Controlled Trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch5 · Cited by 238
Mason, E. E. (1992) · Obesity Surgery · doi:10.1381/096089292765560187 · Cited by 238
Allison, D., Zannolli, R., Faith, M., Heo, M., Pietrobelli, A., Vanltallie, T., Pi-Sunyer, F., & Heymsfield, S. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800875 · Cited by 236
Weissman, N. J., Tighe, J. F., Gottdiener, J. S., & Gwynne, J. T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391103 · Cited by 223
Lindgärde, F. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00720.x · Cited by 204
Type ii diabetic subjects lose less weight than their overweight nondiabetic spouses
Wing, R. R., Marcus, M. D., Epstein, L. H., & Salata, R. (1987) · Diabetes Care · doi:10.2337/diacare.10.5.563 · Cited by 190
Methods for Voluntary Weight Loss and Control
Panel, N. T. A. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00026 · Cited by 166
The impact of obesity on health status: some implications for health care costs.
Seidell, J. C. (1995) · PubMed · Cited by 160
French, S. A., Folsom, A. R., Jeffery, R. W., & Williamson, D. F. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009844 · Cited by 156
Smith, I. G., & Goulder, M. A. (2001) · PubMed · Cited by 149
O’Meara, S., Riemsma, R., Shirran, L., Mather, L., & ter Riet, G. (2001) · Health Technology Assessment · doi:10.3310/hta5180 · Cited by 117
McMahon, F. G., Weinstein, S. P., Rowe, E., Ernst, K. R., Johnson, F., & Fujioka, K. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001298 · Cited by 116
Broom, J. I., Wilding, J. P. H., Stott, P., Myers, N., & UK Multimorhidity Study Group (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11307.x · Cited by 115
Bakris, G. L., Calhoun, D. A., Egan, B. M., Hellmann, C. P., Dolker, M., & Kingma, I. (2002) · Journal of Hypertension · doi:10.1097/00004872-200211000-00026 · Cited by 102
The Association between Weight Loss and Increased Longevity: A Review of the Evidence
Williamson, D. F., & Pamuk, E. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00021 · Cited by 79
Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias.
Wooltorton, E. (2002) · Europe PMC (PubMed Central) · Cited by 55
O’Meara, S., Riemsma, R. P., Shirran, L., Mather, L., & ter Riet, G. (2002) · Health Technology Assessment · doi:10.3310/hta6060 · Cited by 45
(2003) · Diabetes Care · doi:10.2337/diacare.26.3.971 · Cited by 9
Cited by
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735
“The remaining 28 publications were rated good or fair quality and included in the evidence base that was used to formulate the ESs and recommendations (12-39).”
BackgroundLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Pi-Sunyer, F. X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & RIO-North America Study Group, F. T. (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,218
Metadata
- Authors
- Padwal, R., Li, S. K., & Lau, D. C. W.
- Affiliations
- University of Alberta Hospital (CA)
- University of Calgary (CA)
- Corresponding author
- Padwal, R
- ORCID
- Venue
- International Journal of Obesity
- Published
- 2003-09-16
- Volume
- 27
- Issue
- 12
- Pages
- 1437-1446
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2135749311
- Cited by
- 348
- References
- 57
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 11 · 2014: 13 · 2013: 21 · 2012: 20
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- anti-obesity drugs, orlistat, sibutramine, obesity, overweight, weight loss, long-term efficacy, drug safety, gastrointestinal adverse effects, blood pressure, cardiovascular risk
- MeSH terms
- Orlistat, Cyclobutanes, Humans, Lactones, Obesity, Randomized Controlled Trials as Topic, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.